Cargando…

A Case Series: Adjunctive Treatment of Major Depressive Disorder in the Geriatric Population with the Methylphenidate Patch

Major depressive disorder can affect anyone regardless of age. In geriatric populations depression is often overlooked and untreated, which subsequently may lead to serious consequences. Almost one third of elderly patients with depression fail to respond to initial treatment and require adjunctive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Kamal, Collins, Ashley, Holroyd, Suzanne, Benja Lamyaithong, Andre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925763/ https://www.ncbi.nlm.nih.gov/pubmed/31886000 http://dx.doi.org/10.1155/2019/2890913

Ejemplares similares

Transdermal Therapy for Attention-Deficit Hyperactivity Disorder with the Methylphenidate Patch (MTS)
por: Findling, Robert L., et al.
Publicado: (2014)

Use of methylphenidate in the treatment of major depressive disorder in an outpatient mental health center
por: Lacueva, Carolina Garnier, et al.
Publicado: (2010)

Low-Charge Electrotherapy in Geriatric Major Depressive Disorder Patients: A Case Series
por: Kong, Xiao-ming, et al.
Publicado: (2019)

Use of Methylphenidate in Coexisting Major Depression, Loss of Libido and Erectile Dysfunction
por: Nazlı, Şerif Bora, et al.
Publicado: (2021)

Measuring Response to Adjunctive Therapy Among Individuals with Major Depressive Disorder
por: Forma, Felicia, et al.
Publicado: (2022)

Efficacy of physical activity in the adjunctive treatment of major depressive disorders: preliminary results
por: Pilu, Alessandra, et al.
Publicado: (2007)

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study
por: Davis, Lori L., et al.
Publicado: (2016)

Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder
por: Vieta, Eduard, et al.
Publicado: (2019)

Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial
por: Shim, Se-hoon, et al.
Publicado: (2022)

Effectiveness of methylphenidate as augmentation therapy after failure of adjunctive neuromodulation for patients with treatment-refractory bipolar depression: a case report
por: Adida, Marc, et al.
Publicado: (2014)

Adjunctive transcranial alternating current stimulation for patients with major depressive disorder: A systematic review and meta-analysis
por: Zheng, Wei, et al.
Publicado: (2023)

Alopecia Associated with Use of Methylphenidate: A Case Series
por: Gnanavel, Sundar, et al.
Publicado: (2018)

Improving physical quality of life with group physical activity in the adjunctive treatment of major depressive disorder
por: Carta, Mauro Giovanni, et al.
Publicado: (2008)

Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy
por: Nelson, J. Craig, et al.
Publicado: (2014)

Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder
por: Yan, Tingjian, et al.
Publicado: (2020)

Intranasal Oxytocin as an adjunct treatment in patients with major depression with and without comorbid borderline personality disorder
por: Maoz, H.
Publicado: (2023)

Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial [ISRCTN64132371]
por: Akhondzadeh, Shahin, et al.
Publicado: (2004)

Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes
por: Spielmans, Glen I., et al.
Publicado: (2013)

Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder
por: Safavi, Parvin, et al.
Publicado: (2016)

Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder
por: Seetasith, Arpamas, et al.
Publicado: (2019)

Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a “real-world” chart review study
por: De Berardis, Domenico, et al.
Publicado: (2020)

Adjunctive Bright Light Therapy for Non-Seasonal Major Depressive Disorder: A Randomized Controlled Trial
por: Chen, I-Peng, et al.
Publicado: (2022)

Diagnostic accuracy of the Geriatric Depression Scale-30, Geriatric Depression Scale-15, Geriatric Depression Scale-5 and Geriatric Depression Scale-4 for detecting major depression: protocol for a systematic review and individual participant data meta-analysis
por: Benedetti, Andrea, et al.
Publicado: (2018)

Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder
por: Martinez, James M, et al.
Publicado: (2015)

Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies
por: Weiller, Emmanuelle, et al.
Publicado: (2017)

PS151. Adjunctive brexpiprazole (OPC-34712) in patients with major depressive disorder and anxiety symptoms: an exploratory study
por: Davis, Lori, et al.
Publicado: (2016)

Adjunctive brexpiprazole for elderly patients with major depressive disorder: An open‐label, long‐term safety and tolerability study
por: Lepola, Ulla, et al.
Publicado: (2018)

Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial
por: Guimarães, Mara C., et al.
Publicado: (2021)

Adjunctive repetitive transcranial magnetic stimulation for adolescents with first-episode major depressive disorder: a meta-analysis
por: Sun, Chen-Hui, et al.
Publicado: (2023)

The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder
por: Aryan, Nazanin, et al.
Publicado: (2020)

Balance Training as an Adjunct to Methylphenidate: A Randomized Controlled Pilot Study of Behavioral Improvement Among Children With ADHD in China
por: Feng, Lei, et al.
Publicado: (2021)

Methylphenidate use in children with attention deficit hyperactivity disorder
por: Machado, Felipe Salles Neves, et al.
Publicado: (2015)

A prospective observational cohort study to screen major depressive disorders in geriatric oncology—Comparison of different scales
por: Boudin, Guillaume, et al.
Publicado: (2022)

Strategy to Accelerate or Augment the Antidepressant Response and for An Early Onset of SSRI Activity. Adjunctive Amisulpride to Fluvoxamine in Major Depressive Disorder
por: Hardoy, Maria Carolina, et al.
Publicado: (2010)

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies
por: Thase, Michael E, et al.
Publicado: (2018)

Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial
por: Fava, Maurizio, et al.
Publicado: (2018)

Efficacy of Brexpiprazole as Adjunctive Treatment in Major Depressive Disorder With Irritability: Post Hoc Analysis of 2 Pivotal Clinical Studies
por: Fava, Maurizio, et al.
Publicado: (2017)

Efficacy of Gemfibrozil as an Adjunct to Sertraline in Major Depressive Disorder, A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial
por: Zandifar, Atefeh, et al.
Publicado: (2021)

Whole-body cryotherapy as adjunct treatment of depressive and anxiety disorders
por: Rymaszewska, Joanna, et al.
Publicado: (2008)

Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith–Magenis syndrome: protocol for a series of N-of-1 trials
por: Müller, A. R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kcb6q56qp31lbhofdp6pt7onsj